Gadolinium (bis{2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}amino)acetate - (2R,3R,4R,5S)-6-(methylamino)-1,2,3,4,5-hexanepentol (1:1:2) (non-preferred name)(CAS: 86050-77-3)

Gadolinium (bis{2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}amino)acetate - (2R,3R,4R,5S)-6-(methylamino)-1,2,3,4,5-hexanepentol (1:1:2) is a chelating agent used as a gadolinium-based contrast agent in magnetic resonance imaging (MRI).

The primary use is as a gadolinium-based contrast agent in MRI. It enhances the visualization of internal organs, tissues, and tumors. It is also used in research for studying the behavior of gadolinium in biological systems.

Gadolinium (bis{2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}amino)acetate - (2R,3R,4R,5S)-6-(methylamino)-1,2,3,4,5-hexanepentol (1:1:2) is generally considered safe for use as an MRI contrast agent. However, it can cause nephrogenic systemic fibrosis in patients with severe renal impairment. Appropriate safety measures and precautions should be observed during handling and administration.

Store in a cool, dry place, protected from light and moisture. Keep the compound in a tightly sealed container. Avoid exposure to temperatures above 30°C and maintain a relative humidity below 60%. Ensure proper ventilation in the storage area and use appropriate personal protective equipment (PPE) when handling.